PanTheryx (Boulder, CO) has acquired TruBiotics, a daily probiotic supplement brand, and its trademarks from New Jersey-based Bayer HealthCare LLC. The TruBiotics brand will join PanTheryx’s current brands and ingredient offerings, including Life’s First Naturals, dairy colostrum, and prebiotics, to create a full spectrum of nutritional supplements that support comprehensive digestive and immune health at all stages of life.

“The acquisition of TruBiotics is consistent with our strategy to accelerate growth through acquisitions of synergistic brands in fast-growing strategic categories,” said Wes Parris, president and CEO of PanTheryx. “We are looking forward to accelerating growth in the probiotics and microbiome category through innovation and investment behind this well established and high-quality brand.”

TruBiotics contains a proprietary blend of two probiotic strains—Bifidobacterium animalis BB-12 and Lactobacillus acidophilusLA-5,^‡ which is one of the most researched combinations of probiotic strains., according to the company. Two types of beneficial bacteria found in the gut—bifidobacteria and lactobacillus—are important for both digestive and immune health support.

“Delivering strong TruBiotics growth is a strategic priority and we are pleased that Bayer is entrusting PanTheryx with the future of this highly respected probiotic brand,” said David Abramson, executive chairman of the board of PanTheryx. “We could not be more energized by this naturally synergistic acquisition.”

According to Grandview Research, the global probiotics market is expected to reach $77 billion U.S. dollars by 2025. The growth of this market is driven by heightened awareness of preventive healthcare among consumers, research focused on the multiple health benefits of probiotics and increased use of probiotics as alternatives to antibiotics.

“An extensive body of research demonstrates the benefits of probiotics in supporting a healthy digestive and immune system,” said Mehmet Oz, MD, attending physician at New York Presbyterian – Columbia Medical Center, host of The Dr. Oz Show, and PanTheryx board member.  I’m excited to see PanTheryx commit to the rapidly growing category of probiotics and I look forward to helping consumers better understand the wonderful health benefits in this area.”

TruBiotics will continue to be available through existing retail and e-commerce channels and will be marketed under the PanTheryx portfolio of products.

‡BB-12 and LA-5 are registered trademarks of Chr. Hansen A/S.

For more information, visit www.pantheryx.com.